1-5 of 5
Max Stahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical characteristics, disease progression, and vascular events in essential thrombocythemia: A single-center cohort study with long-term follow-up.

Free
Daniil Katkov, Lourdes Mendez, Nikolai Podoltsev, Max Stahl, Amer Zeidan, Jan Philipp Bewersdorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 7322.
https://doi.org/10.1182/blood-2025-7322
Published: 2025
Journal Articles

Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database

Free
Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, Wei Wei, Najla Al Ali, Amy DeZern, Mikkael Sekeres, Geoffrey Uy, Samuel Urrutia, Hetty Carraway, Pinkal Desai, Elizabeth Griffiths, Eytan Stein, Andrew Brunner, Christine McMahon, Rory Shallis, Joshua Zeidner, Michael Savona, Hayley Hawkins, Namrata Chandhok, Constantine Logothetis, Aram Bidikian, Theodore Getz, Gail Roboz, Benjamin Rolles, Eunice Wang, Amyah Harris, Maria Amaya, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan Madanat, Yasmin Abaza, Jaclynn Campos, Talha Badar, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop Enjeti, Kamal Alrabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Max Stahl, Matteo Della Porta, Rami Komrokji, Amer Zeidan
Journal: Blood
Blood (2025) 146 (Supplement 1): 606.
https://doi.org/10.1182/blood-2025-606
Published: 2025
Journal Articles

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Free
Amir Fathi, Alexander Perl, Geoffrey Fell, Brian Jonas, Brittany Ragon, Alice Mims, Uma Borate, Gabriel Mannis, Karen Quillen, Max Stahl, Paul Koller, Andrew Artz, Monzr M. Al Malki, Guido Marcucci, Mary Linton Peters, Timothy Graubert, Peter Westervelt, Philip Amrein, Hanno Hock, Andrew Brunner, Gabriela Hobbs, Rupa Narayan, Michelle Lee, Brandon Aubrey, Alyssa Watson, Richard Hao, Shilton Dhaver, Michael Grunwald, Yi-Bin Chen, Andrew Matthews, Christopher Hourigan, Brent Wood, Donna Neuberg, Areej El-Jawahri, Ibrahim Aldoss
Journal: Blood
Blood (2025) 146 (Supplement 1): 6.
https://doi.org/10.1182/blood-2025-6
Published: 2025
Journal Articles

Acute myeloid leukemia (AML) after myeloproliferative neoplasm (MPN): Real-world outcomes in the new AML treatment era

Free
Jan Philipp Bewersdorf, Rong Wang, Lourdes Mendez, Max Stahl, Amer Zeidan, Xiaomei Ma, Nikolai Podoltsev
Journal: Blood
Blood (2025) 146 (Supplement 1): 721.
https://doi.org/10.1182/blood-2025-721
Published: 2025
Journal Articles

A multi-site break through cancer pilot study testing the feasibility and safety of therapeutic intervention for patients with high-risk clonal cytopenia of undetermined significance (CCUS)

Free
Danielle Hammond, Amy DeZern, Kelly Chien, Sanam Loghavi, Geoffrey Fell, Darren Evanchuk, Eytan Stein, Sam Sadigh, Rena Xian, Wenbin Xiao, Guillermo Garcia-Manero, Max Stahl, Lachelle Weeks
Journal: Blood
Blood (2025) 146 (Supplement 1): 3160.
https://doi.org/10.1182/blood-2025-3160
Published: 2025